EurekaMag.com logo
+ Translate

Hepatoxicity of ketoconazole in men and in patients under 50


, : Hepatoxicity of ketoconazole in men and in patients under 50. New England Journal of Medicine 316(25): 1606

Commenting on a report by Sobel (Sobel, J.D. N. Engl.

(PDF 0-2 workdays service)

Accession: 001607530

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Caballería Rovira, E.; Massó Ubeda, R.M.; Aragó López, J.V.; Sanchis Closa, A., 1986: Ketoconazole hepatoxicity. Apropos of a case. Medicina Clinica 86(7): 303-304

Lint, J. van; Doncker, P. de; Woestenborghs, R., 1988: Chronic use of 2% ketoconazole shampoo in patients with seborrheic dermatitis and dandruff. Ketoconazole plasma levels and safety. Thirty-three patients (18 males, 15 females) presenting with seborrhoeic dermatitis [Malassezia furfur infection] and dandruff washed their hair with a 2% ketoconazole shampoo, twice to three times weekly. Before entering the study and after a tre...

Hedayati,M.T.; Hajjar,F.H.E.; Ehsani,A.; Hajheydari,Z.; Shokoohi,T.; Mohammadpour,R.A.; Toliyat,T., 2008: The effect of ketoconazole 2% solution in comparison with ketoconazole 2% shampoo on clinicalsigns and Malassezia yeasts in seborrhoeic dermatitis patients. The effects of ketoconazole 2% solution and shampoo on the clinical signs and <i>Malassezia</i> yeasts load of patients with seborrhoeic dermatitis (SD) were compared. 100 SD patients [in Iran] were enrolled in the study. They were sco...

Van Lint J.; D.D.ncker P.; Woestenborghs R., 1988: Chronic use of 2 percent ketoconazole shampoo in patients with seborrheic dermatitis and dandruff ketoconazole plasma levels and safety. Thirty-three patients (18 males, 15 females) presenting with seborrheic dermatitis and dandruff washed their hair with a 2% ketoconazole shampoo, twice to three times weekly. Before entering the study and after a treatment duration of three to 26...

Figg, W.D.; Liu, Y.; Arlen, P.; Gulley, J.; Steinberg, S.M.; Liewehr, D.J.; Cox, M.C.; Zhai, S.; Cremers, S.; Parr, A.; Yang, X.; Chen, C.C.; Jones, E.; Dahut, W.L., 2005: A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases. Purpose: Alendronate (AL), a potent oral bisphosphonate, blocks the secretion of matrix metalloproteinase-2 and the establishment of bone metastases in animal models. Ketoconazole (KT) has demonstrated activity in androgen independent prostate can...

Wang, K.; Wu, Y.; Chi, Z.; Shu, C.; Li, L.; Wei, J.; Tao, L.; Ma, P.; Ding, L., 2016: A highly sensitive LC-MS/MS method for determination of ketoconazole in human plasma: Application to a clinical study of the exposure to ketoconazole in patients after topical administration. A simple, rapid and highly sensitive LC-MS/MS method was developed and validated for the determination of ketoconazole in human plasma. Sample preparation was accomplished through a single step liquid-liquid extraction by ethyl acetate. The chroma...

de Repentigny, L.; Ratelle, J., 1996: Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group. The efficacy of oral itraconazole and ketoconazole in the treatment of oropharyngeal and/or esophageal candidiasis, and the rate of post-treatment relapse, were compared in a multicenter, prospective, double-blind, double-dummy, randomized, parall...

Yeo, C.Meng.; Chong, V.Heng.; Earnest, A.; Yang, W.Lyn., 2013: Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. To establish the prevalence of liver fibrosis and to evaluate the possible risk factors for fibrosis and progression in Asian with psoriasis treated with methotrexate (MTX) based on liver histology. Patients with psoriasis treated with MTX referre...

Nakabayashi, M.; Xie, W.; Regan, M.M.; Jackman, D.M.; Kantoff, P.W.; Oh, W.K., 2016: Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. Journal of Clinical Oncology 24(18_suppl): 4646-4646

Chen, S.C.; Barker, S.M.; Mitchell, D.H.; Stevens, S.M.; O'Neill, P.; Cunningham, A.L., 1992: Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection. Myopathy and hepatic toxicity are important complications of zidovudine (3'-azido-3'-deoxythymidine therapy) in patients infected with the human immunodeficiency virus (HIV) both may also occur in HIV infection in the absence of zidovudi...